2025-05-16 - Analysis Report
Okay, here's an analysis of Albemarle Corp (ALB) based on the provided data, in English, with a focus on key numbers and insights:

**Albemarle Corp (ALB) Stock Analysis**

**0. Executive Summary**

Albemarle Corp. (ALB) is a specialty chemicals company with leading positions in lithium, bromine, and catalysts.

**1. Performance Relative to S&P 500 (VOO)**

*   **ALB Cumulative Return:** 4.87%
*   **VOO Cumulative Return:** 81.82%
*   **Absolute Divergence (ALB - VOO):** -77.0
*   **Relative Divergence:** 0.0 (indicating ALB is at the lowest end of its historical divergence range compared to VOO).

**Analysis:**  ALB has significantly underperformed the S&P 500 (VOO) over the period examined.  The relative divergence suggests this underperformance is at the lower end of its historical range.

**Alpha/Beta Analysis Table:**

| Year       | CAGR    | MDD    | Alpha   | Beta | Cap(B) |
|------------|---------|--------|---------|------|--------|
| 2015-2017  | 99.0%   | 7.7%   | 70.0%   | 0.0  | 13.7   |
| 2016-2018  | 13.0%   | 58.1%  | -5.0%   | 0.0  | 8.4    |
| 2017-2019  | -45.0%  | 58.1%  | -74.0%  | -0.0 | 8.1    |
| 2018-2020  | 101.0%  | 62.9%  | 75.0%   | 0.7  | 16.6   |
| 2019-2021  | 268.0%  | 62.9%  | 214.0%  | 0.8  | 26.5   |
| 2020-2022  | 239.0%  | 75.8%  | 233.0%  | 1.1  | 24.8   |
| 2021-2023  | -53.0%  | 77.6%  | -69.0%  | 0.6  | 16.6   |
| 2022-2024  | -204.0% | 77.6%  | -221.0% | 0.8  | 10.1   |
| 2023-2025  | -343.0% | 77.6%  | -373.0% | 3.2  | 7.0    |

**Analysis:**

*   **CAGR & MDD:**  The table shows highly variable performance across different 3-year periods. Recent periods (2021-2025) exhibit significant negative CAGR and high Maximum Drawdown (MDD), indicating substantial losses and volatility.
*   **Alpha:**  Alpha is largely positive in earlier periods but turns sharply negative in recent years, showing significant underperformance relative to the market.
*   **Beta:** Beta is generally below 1, except for the last period, indicating that ALB's price is less sensitive to market movements than the S&P 500, but that is changing.
*   **Cap:** The company's market cap has fluctuated considerably over the years.

**2. Recent Price Action**

*   **Current Price:** 59.755
*   **Last Market Data:** Price: 59.715, Previous Close: 61.08, Change: -2.23
*   **5-day Moving Average:** 58.551
*   **20-day Moving Average:** 57.1592
*   **60-day Moving Average:** 67.4363

**Analysis:** The price is currently below its 60-day moving average but above the 5-day and 20-day moving averages. The last market data shows a negative change, suggesting downward price pressure.

**3. Technical Indicators**

*   **Market Risk Indicator (MRI):** 0.35 (Low Risk)
*   **RSI:** 60.87 (approaching overbought territory)
*   **PPO:** 1.51
*   **Change in 20-day Relative Divergence:** -0.2 (Indicates short-term decline in relative performance)
*   **Expected Return:** 13651.8% (Long-term, relative to S&P 500). The provided number is very high, and it's very unlikly and should be verified if is correct, it suggest substantial outperformance over the long term if is real.

**Analysis:**

*   The MRI suggests low market risk.
*   The RSI is close to overbought territory, potentially signaling a possible pullback.
*   The negative change in relative divergence confirms recent underperformance compared to the S&P 500.
*   The negative change in relative divergence and the recent price decrease {'price': 59.715, 'previousClose': 61.08, 'change': -2.23}  indicates recent downward pressure.

**4. Recent News & Significant Events**

*   **May 12, 2025:** Major business developments, regulatory changes, or market events.
*   **May 13, 2025:** Analysts discussing ALB's performance and outlook.
*   **May 15, 2025:** Notable stock volatility.
*   **May 16, 2025:** Market experts highlight both risks and opportunities.

**Analysis:** Recent news points to active developments, analyst scrutiny, and volatility in ALB's stock.  Investors are advised to stay informed on company announcements and news.

**5. Overall Assessment**

Albemarle (ALB) has significantly underperformed the S&P 500 recently, and its historical alpha has deteriorated. While the MRI indicates low market risk, recent price action and technical indicators suggest potential downward pressure and volatility. The extremely high expected return should be verified. Recent news suggests the company is experiencing significant events that warrant close monitoring.
